SHINE allowed more flexibility in procuring production components

May 18, 2021, 9:29AMNuclear News
SHINE executives, construction managers, and partners commemorate a construction milestone of the medical isotope production facility in March. (Photo: SHINE)

The Nuclear Regulatory Commission has approved a request by SHINE Medical Technologies for an exemption from regulations on how commercial grade equipment is defined, allowing the company to more easily procure components for the medical isotope production facility it is building in Janesville, Wis.

To continue reading, log in or create a free account!

Related Articles

On moving fast and breaking things

March 16, 2026, 9:33AMNuclear NewsCraig Piercy

So much of what is happening in federal nuclear policy these days seems driven by a common approach popularized in the technology sector. Silicon Valley calls it “move fast and break...